chr5-150115690-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002609.4(PDGFRB):c.*73A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.408 in 1,407,234 control chromosomes in the GnomAD database, including 121,062 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.39 ( 12297 hom., cov: 32)
Exomes 𝑓: 0.41 ( 108765 hom. )
Consequence
PDGFRB
NM_002609.4 3_prime_UTR
NM_002609.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.408
Publications
17 publications found
Genes affected
PDGFRB (HGNC:8804): (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]
PDGFRB Gene-Disease associations (from GenCC):
- acroosteolysis-keloid-like lesions-premature aging syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- myofibromatosis, infantile, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- basal ganglia calcification, idiopathic, 4Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- bilateral striopallidodentate calcinosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile myofibromatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary progressive mucinous histiocytosisInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 5-150115690-T-C is Benign according to our data. Variant chr5-150115690-T-C is described in ClinVar as Benign. ClinVar VariationId is 1221159.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.429 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PDGFRB | NM_002609.4 | c.*73A>G | 3_prime_UTR_variant | Exon 23 of 23 | ENST00000261799.9 | NP_002600.1 | ||
| PDGFRB | NM_001355016.2 | c.*73A>G | 3_prime_UTR_variant | Exon 22 of 22 | NP_001341945.1 | |||
| PDGFRB | NM_001355017.2 | c.*73A>G | 3_prime_UTR_variant | Exon 23 of 23 | NP_001341946.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.394 AC: 59905AN: 151914Hom.: 12274 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
59905
AN:
151914
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.410 AC: 514094AN: 1255202Hom.: 108765 Cov.: 18 AF XY: 0.407 AC XY: 250524AN XY: 615562 show subpopulations
GnomAD4 exome
AF:
AC:
514094
AN:
1255202
Hom.:
Cov.:
18
AF XY:
AC XY:
250524
AN XY:
615562
show subpopulations
African (AFR)
AF:
AC:
11329
AN:
27296
American (AMR)
AF:
AC:
6715
AN:
25898
Ashkenazi Jewish (ASJ)
AF:
AC:
8538
AN:
18716
East Asian (EAS)
AF:
AC:
3980
AN:
36428
South Asian (SAS)
AF:
AC:
20261
AN:
63326
European-Finnish (FIN)
AF:
AC:
10005
AN:
40274
Middle Eastern (MID)
AF:
AC:
1585
AN:
3512
European-Non Finnish (NFE)
AF:
AC:
430686
AN:
987544
Other (OTH)
AF:
AC:
20995
AN:
52208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
13988
27976
41964
55952
69940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13294
26588
39882
53176
66470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.394 AC: 59971AN: 152032Hom.: 12297 Cov.: 32 AF XY: 0.382 AC XY: 28400AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
59971
AN:
152032
Hom.:
Cov.:
32
AF XY:
AC XY:
28400
AN XY:
74326
show subpopulations
African (AFR)
AF:
AC:
17527
AN:
41442
American (AMR)
AF:
AC:
5406
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1604
AN:
3468
East Asian (EAS)
AF:
AC:
569
AN:
5154
South Asian (SAS)
AF:
AC:
1569
AN:
4814
European-Finnish (FIN)
AF:
AC:
2485
AN:
10604
Middle Eastern (MID)
AF:
AC:
140
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29467
AN:
67952
Other (OTH)
AF:
AC:
856
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1895
3790
5686
7581
9476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
773
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.